Wolff Wiese Magana’s Dogwood Therapeutics DWTX Stock Holding History

Wolff Wiese Magana’s Portfolio DWTX Stock Details DWTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-2	Closed	–	–	994
2022 Q1	$0	Hold	2	–	–	﹤0.01%	866
2021 Q4	$0	Buy	+2	New	+$254	﹤0.01%	869

Other funds holding DWTX

MCM

Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Cetera Advisors Denver, Colorado $12.7B AUM 22.7% 1-Year Est. Return

Koshinski Asset Management Decatur, Illinois $1.88B AUM 29.07% 1-Year Est. Return

CAPTRUST Financial Advisors Raleigh, North Carolina $57.3B AUM 18.32% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

&Partners Nashville, Tennessee $20.2B AUM 19.79% 1-Year Est. Return

Wolff Wiese Magana's DWTX Position: Q2 2022 in Review

Wolff Wiese Magana sold out of Dogwood Therapeutics (DWTX) in Q2 2022, closing a stake of 2 shares.

Wolff Wiese Magana first reported a position in DWTX in Q4 2021 and held it in 2 quarters. The position peaked at $0 in Q1 2022. 17 funds tracked by Wall St. Rank hold DWTX as of Q2 2022.

Wolff Wiese Magana reported no remaining Dogwood Therapeutics position as of Q2 2022 after selling out during the quarter.
Wolff Wiese Magana sold 2 Dogwood Therapeutics shares in Q2 2022.
Wolff Wiese Magana first reported a position in Dogwood Therapeutics in Q4 2021 and held it in 2 quarters.
Wolff Wiese Magana's Dogwood Therapeutics position peaked at $0 in Q1 2022.
17 funds tracked by Wall St. Rank held Dogwood Therapeutics as of Q2 2022.

Based on Wolff Wiese Magana's 13F filing for Q2 2022, filed 15 Jul 2022.